Financial Times  57 min ago  Comment 
Commitment follows WHO declaration of global public health emergency
FiercePharma  Feb 1  Comment 
Novo NordiskĀ has some new data in hand that could help a safety advantage make its way onto the label of new drugĀ Tresiba--and win it points against heavyweight rival Sanofi. In a recent study, the med hit its primary endpoint, cutting the...
newratings.com  Jan 29  Comment 
PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) and the Iran Food and Drug Administration, affiliated to the Ministry of Health and Medical Education of the Islamic Republic of Iran, have signed a Memorandum of Cooperation to start discussions in order to...
FierceBiotech  Jan 27  Comment 
Struggling drugmaker MannKind is looking for a way out of its perilous financial situation, according to Reuters, scouting for a buyer in the wake of ex-partner Sanofi's decision to abandon the company and its inhaled insulin.
FiercePharma  Jan 26  Comment 
One of the hottest races for market share in pharma these days is between Amgen's cholesterol-fighter Repatha and Praluent, from Sanofi and Regeneron. They're apparently neck and neck with payers, and their script numbers aren't much different...
FierceBiotech  Jan 22  Comment 
French drugmaker Sanofi is soon to announce some "sizable" cuts to its payroll, according to Stat, part of new CEO Olivier Brandicourt's plot to engineer a turnaround.
FierceBiotech  Jan 21  Comment 
MannKind, decimated by the departure of former co-signer Sanofi, is trying to conserve value in the face of sluggish sales for its inhaled insulin, signing a deal to transfer some of its pipeline to an obscure new company.
FiercePharma  Jan 20  Comment 
Predicting the future--particularly when it comes to Big Pharma's prospects for growth and earnings--is a favorite pastime among industry-watchers. Even better when the predictions come from analysts who've dug deeply into company numbers and...
newratings.com  Jan 14  Comment 
PARIS (dpa-AFX) - Sanofi Pasteur, the vaccines division of Sanofi (SNYNF, SNY), announced Thursday that it has signed an agreement with the Human Vaccines Project Inc. to partially fund the non-profit, public-private partnership. The research...
FiercePharma  Jan 13  Comment 
SAN FRANCISCO--On Monday, we brought you the lowdown from the J.P. Morgan Healthcare Conference, with company presentations from pharma giants including Novartis and Merck & Co. Today, we're back with our latest roundup, big names and not-so-big.


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki